Current position in this corpus
The newest protocols in this collection do not stop at making organoids. They increasingly add gene editing, pooled perturbation, viral delivery, advanced imaging, or whole-mount preparation to turn organoids into higher-leverage experimental systems.
Strong supporting sources
Working synthesis
- Engineering layers make organoids much more useful for mechanism, screening, and lineage interrogation.
- At the same time, these workflows usually assume that the baseline organoid pipeline is already stable and reproducible.
- The practical bottleneck often shifts from differentiation itself to delivery, imaging quality, screen design, or readout normalization.
Main tension
- organoid generation as an endpoint versus organoid generation as a platform for perturbation
- experimental leverage versus technical overhead
Open questions
- Which engineering layer adds the most insight for the least extra protocol burden?
- How should screening or imaging workflows be standardized across organoid lines and batches?